Comments
Loading...
Xilio Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:XLO | Benzinga
Xilio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS
$-0.200
Quarterly Revenue
$1.72M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.34M
Analyze the earnings history of Xilio Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics | -$0.59 | — | — | — | $0.00 | — | — | — | 05/13/2025 | Get Alert |
| XLO | Xilio Therapeutics | -$0.64 | -$0.24 | -$0.20 | 16.67% | $0.00 | — | $1.72M | — | 03/11/2025 | Get Alert |
| XLO | Xilio Therapeutics | -$0.61 | -$0.25 | -$0.22 | 12.00% | $0.00 | $3.30M | $2.26M | -31.42% | 11/07/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.70 | -$0.23 | -$0.24 | -4.35% | $0.00 | — | $2.36M | — | 08/08/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.83 | -$0.11 | -$0.59 | -436.36% | $0.00 | $30.00M | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.82 | -$0.74 | -$0.64 | 13.51% | $0.00 | — | $0.00 | — | 04/01/2024 | Get Alert |
| XLO | Xilio Therapeutics | -$0.72 | -$0.81 | -$0.61 | 24.69% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.90 | -$0.87 | -$0.70 | 19.54% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.78 | -$0.89 | -$0.83 | 6.74% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$0.98 | -$0.78 | -$0.82 | -5.13% | $0.00 | — | $0.00 | — | 03/02/2023 | Get Alert |
| XLO | Xilio Therapeutics | -$21.27 | -$0.88 | -$0.72 | 18.18% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$31.48 | — | -$0.90 | — | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$23.53 | — | -$0.78 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$31.51 | -$1.17 | -$0.98 | 16.24% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| XLO | Xilio Therapeutics | -$24.19 | -$1.60 | -$21.27 | -1229.37% | $0.00 | — | $0.00 | — | 12/02/2021 | Get Alert |
Xilio Therapeutics (XLO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.20 | $-0.24 | 16.7 % |
| Q3 | 2024-11-07 | $-0.22 | $-0.25 | 12.0 % |
| Q2 | 2024-08-08 | $-0.24 | $-0.23 | -4.35 % |
| Q1 | 2024-05-14 | $-0.59 | $-0.11 | -436.4 % |
Xilio Therapeutics (XLO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $2.26M | $3.30M | -31.4 % |
| Q1 | 2024-05-14 | $0 | $30.00M | -100.0 % |
FAQ
When is Xilio Therapeutics (NASDAQ:XLO) reporting earnings?
Xilio Therapeutics (XLO) is scheduled to report earnings on May 13, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Xilio Therapeutics (NASDAQ:XLO)?
The Actual EPS was $-0.20, which beat the estimate of $-0.24.
What were Xilio Therapeutics’s (NASDAQ:XLO) revenues?
The Actual Revenue was $1.7M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.